Skip to Content

Tasimelteon Pregnancy and Breastfeeding Warnings

Tasimelteon is also known as: Hetlioz

Tasimelteon Pregnancy Warnings

This drug should be used during pregnancy only if the potential benefit outweighs the potential risk. US FDA pregnancy category: C

Animal studies have revealed evidence of embryolethality and embryofetal toxicity. Adverse effects included reduced fetal body weight, delayed ossification, delayed sexual maturation and physical development, and neurobehavioral impairment in offspring at doses greater than the recommended human dose (RHD). The highest dose not associated with adverse effects (30 mg/kg/day) is approximately 30 times the RHD. In animal fertility studies, estrus cycle disruption and decreased fertility were observed. The no-effect dose for female reproductive effects is approximately 2 times the RHD. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Tasimelteon Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Hetlioz (tasimelteon)." Vanda Pharmaceuticals Inc, Rockville, MD.

References for breastfeeding information

  1. "Product Information. Hetlioz (tasimelteon)." Vanda Pharmaceuticals Inc, Rockville, MD.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.